Binge Eating Disorder
📧 Sign up to get email alerts when something new happens for Binge Eating Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves lisdexamfetamine dimesylate (generic) from Mylan as an Original Application; the generic is approved for the same indications a…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (SpecGx LLC)
FDA approved lisdexamfetamine dimesylate under an Original Application (generic) filed by SpecGx LLC.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Alvogen Inc.)
FDA approved the original ANDA for lisdexamfetamine dimesylate (generic) from Alvogen, enabling a generic version of the ADHD and binge eati…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva's original ANDA for lisdexamfetamine dimesylate, establishing a generic version of the prodrug used to treat ADHD and …
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Rhodes Pharmaceuticals)
FDA approved an original generic application for lisdexamfetamine dimesylate from Rhodes Pharmaceuticals for the treatment of ADHD and binge…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Lannett Company, Inc.)
FDA approves the original application for lisdexamfetamine dimesylate as a generic drug by Lannett Company, enabling generic supply with the…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA lists Camber Pharmaceuticals' lisdexamfetamine dimesylate as an approved original application (generic) product. The approval covers the…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals LLC's original application for lisdexamfetamine dimesylate as a generic drug. This approval provides a g…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Apotex Corp.)
FDA approves Apotex Corp.'s lisdexamfetamine dimesylate as a generic version of the ADHD and binge eating disorder medication.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a generic lisdexamfetamine dimesylate product under an Original ANDA for the treatment of ADHD and binge-eating disorder.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Solco Healthcare US,LLC)
FDA approved Solco Healthcare US, LLC's lisdexamfetamine dimesylate capsules as an original generic application (ANDA) for ADHD and binge ea…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's lisdexamfetamine dimesylate as an original generic application, confirming a generic version of the stimul…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approves lisdexamfetamine dimesylate as an Original Application (ANDA) for Teva Pharmaceuticals, providing a generic option for the ADHD…
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder [Phase 2, Phase 3]
Phase 2/3 trial updates on efficacy and mechanisms of naltrexone plus bupropion for binge eating disorder, with results posted after complet…
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: A Behavioral Activation Intervention Administered in a College Freshman Orientation Course [Phase 2]
Phase 2 clinical trial update evaluating a behavioral activation intervention delivered in a college freshman orientation course for alcohol…
-
CLINICAL_TRIALS trial_result · 2023-07-07Clinical Trial Update: Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating behavioral and pharmacologic treatment for binge eating and obesity has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating behavioral and pharmacologic maintenance therapy for binge eating disorder and obesity has complete…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder [NA]
Completed clinical trial examining neural responses to food stimuli via fMRI after cognitive behavioral therapy for binge eating disorder; r…
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Uniting Couples in the Treatment of Binge-Eating Disorder [NA]
A completed clinical trial for binge-eating disorder with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder [Phase 2]
Phase 2 multicenter trial assessing the efficacy and safety of oral ACT-539313 in adults with moderate to severe binge eating disorder has c…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Solriamfetol in Binge Eating Disorder [Phase 4]
Clinical trial update for solriamfetol in binge eating disorder in Phase 4 is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: Effect of Nutritional Counseling Associated With Transcranial Direct-current Stimulation in Binge Eating Reduction [Phase 2]
A Phase 2 clinical trial evaluating the effect of nutritional counseling combined with transcranial direct-current stimulation on binge eati…
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment [Phase 2, Phase 3]
Phase 2/Phase 3 trial update on behavioral and pharmacologic treatment for binge eating and obesity has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Binge Eating & Birth Control [Phase 2]
Phase 2 clinical trial update for a study on binge eating and birth control in bulimia nervosa/binge eating disorders; study terminated with…
-
FDA approval · 2022-02-25FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc., indicating …